secwatch.observer — SEC 8-K summary
======================================

Issuer:     DENTSPLY SIRONA Inc. (XRAY)
CIK:        0000818479
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0000818479-25-000167
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dentsply Sirona Retains Wellspect Healthcare After Strategic Review, Ends Sale Process
--------------------------------------------------------------------------------

- Strategic review of Wellspect begun Feb 2025 completed Sep 8, 2025; company decided to retain the business.
- Wellspect is a leader in continence care with LoFric and Navina brands; mid-single digit organic sales growth in 2024.
- CEO Dan Scavilla cited strong cash flow, untapped market potential, and a $2B addressable market for the decision.
- Company conducted broad outreach and considered a sale but determined retention creates more stockholder value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818479/000081847925000167/0000818479-25-000167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818479/000081847925000167/xray-20250908.htm
  HTML page:      https://secwatch.observer/filing/0000818479-25-000167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer